Former 23andMe CEO regains company control as $305m sale to nonprofit approved

A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by its former CEO Anne Wojcicki, effectively putting her back in control of the bankrupt genetics company. Regeneron initially acquired 23andMe for $256m, yet nonprofit TTAM Research Institute subsequently swooped in with a…